Search results
From Proteopedia
You searched for Alzheimer’s
There is no page with the exact title "Alzheimer’s". The search results for "Alzheimer’s" are displayed below. You can create a page titled Alzheimer’s (by clicking on the red link).
For more information about searching Proteopedia, see Help.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
No page title matches
Page text matches
- Andrew Helmerich Sandbox 1 (10,787 bytes)
30: ...tps://en.wikipedia.org/wiki/Alzheimer%27s_disease Alzheimer’s disease] <ref name="Gingell">PMID:24169554</ref>. - User:Eduarda Franco Marcolino/Sandbox 1 (7,658 bytes)
9: ...s with [https://pubmed.ncbi.nlm.nih.gov/33667416/ Alzheimer’s disease], which consequently leads to accumulatio... - User:Alexander Grayzel/Sandbox 1 (15,974 bytes)
52: ... implicated in neurodegenerative diseases such as Alzheimer’s and Parkinson’s, where iron misregulation contr... - Sandbox Reserved 591 (8,094 bytes)
6: ...ndependently using partial protein sequence data. Alzheimer’s disease is caused by accumulation of β-amyloid p...
10: ...J. 2011. Amyloid Precursor Protein Processing and Alzheimer’s Disease. NIH. 34: 185–204. </ref> [[Image:79_ap...
15: ...J. 2011. Amyloid Precursor Protein Processing and Alzheimer’s Disease. NIH. 34: 185–204. </ref> [[Image:nihms... - AChE inhibitors and substrates (53,646 bytes)
50: ..._States) FDA]-approved drugs for the treatment of Alzheimer’s disease, Donepezil (Aricept), Rivastigmine (Exelo... - Category:Acetylcholinesterase (3,924 bytes)
14: Alzheimer’s disease (AD) is a debilitating brain disease that... - Sandbox Reserved 708 (8,395 bytes)
11: ...ournal of biological Chemistry 2005</ref>. In the Alzheimer’s disease, it is thought to be tied to the process ...
13: ...3-inhibitors may act positively in the therapy of Alzheimer’s patients. But due to the importance of its role i...
48: ...cbi.nlm.nih.gov/pmc/articles/PMC3162188/ GSK3 and Alzheimer’s Disease: Facts and Fiction…] - User:Amy Rumora/Sandbox 1 (13,796 bytes)
2: ...[http://en.wikipedia.org/wiki/Alzheimer's_disease Alzheimer’s disease (AD)]. A subsequent cleavage by γ-secre... - User:Christopher French (9,313 bytes)
8: ...in various disease states, including ischemia and Alzheimer’s. Caspase 8 is just one of 11 caspases that have b... - Gamma secretase (20,920 bytes)
10: ...ze to form neurofibrillary tangles and plaques in Alzheimer’s disease.<ref name= "mckeon">DOI:10.1016/B978-0123...
14: ... γ-secretase substrates are APP for its roles in Alzheimer’s Disease, and Notch for its importance in developm...
41: ... familial mutations lead to the heritable form of Alzheimer’s disease.<ref name= "carroll" /> - Human APP Intracellular Domain Complex with Fe65-PTB2 (9,047 bytes)
36: There is an association between Aβ protein and Alzheimer’s disease because it is the major component found i...
38: ...otein are characteristic in the neuropathology of Alzheimer’s disease. Hyperphosphorylated tau protein and accu... - Human APP (9,784 bytes)
79: ...thways for Production of Beta-Amyloid Peptides of Alzheimer’s Disease.Biol Chem. 2008 August; 389(8): 993–100... - Sandbox elodie weider (5,509 bytes)
7: ...onent of brain and of the amyloid islets found in Alzheimer’s disease.
8: ...q and is in a region linked to type 2 diabete and Alzheimer’s disease. - Beta secretase (19,059 bytes)
57: ...ve as drugs in the treatment and/or prevention of Alzheimer’s disease. The protease domain has a conserved aspa... - Sandbox Reserved 595 (32,222 bytes)
21: ...ay be useful in developing therapeutic agents for Alzheimer’s disease. PNAS 109(23):8913-8919.</ref>' '<ref>Nar...
23: ...ay be useful in developing therapeutic agents for Alzheimer’s disease. PNAS 109(23):8913-8919.</ref>'.
26: ...ay be useful in developing therapeutic agents for Alzheimer’s disease. PNAS 109(23):8913-8919.</ref>'.
32: ...ay be useful in developing therapeutic agents for Alzheimer’s disease. PNAS 109(23):8913-8919.</ref>'.
44: ...ay be useful in developing therapeutic agents for Alzheimer’s disease. PNAS 109(23):8913-8919.</ref>'. Residue... - User:Martha Blakely/Sandbox 1 (8,133 bytes)
25: ...AO-A, rather than diseases like Parkinson’s and Alzheimer’s that are associated with higher levels of MAO-B. ... - Sandbox 250 (11,231 bytes)
23: ..., controlled inhibition of AChE, in patients with Alzheimer’s disease, by drugs designed for this purpose, alle... - Monoamine oxidase b (10,371 bytes)
24: ...AO-A, rather than diseases like Parkinson’s and Alzheimer’s that are associated with higher levels of MAO-B. ...
40: ...between MAO-B and diseases like Parkinson’s and Alzheimer’s has promoted the development of medicinal inhibi... - User:David Canner/Sandbox 2 (2,037 bytes)
7: **Alzheimer’s Disease - Pharmaceutical Drug Targets and Diseases (2,578 bytes)
6: **Alzheimer’s Disease
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
